Wstęp
Ta strona zawiera kompleksową analizę znanej historii wykorzystywania informacji poufnych w firmie John D Quisel. Insiderzy to członkowie kadry kierowniczej, dyrektorzy lub znaczący inwestorzy w spółce. Dokonywanie transakcji w ich firmach w oparciu o określone, niepubliczne informacje jest nielegalne. Nie oznacza to, że dokonywanie jakichkolwiek transakcji we własnych firmach jest nielegalne. Muszą jednak zgłaszać wszystkie transakcje do SEC za pośrednictwem formularza 4. Pomimo tych ograniczeń badania akademickie sugerują, że insiderzy – ogólnie rzecz biorąc – mają tendencję do osiągania lepszych wyników na rynku w swoich własnych firmach.
Średnia rentowność handlu
Średnia rentowność handlu to średni zwrot ze wszystkich zakupów na otwartym rynku dokonanych przez osobę mającą dostęp do informacji poufnych w ciągu ostatnich trzech lat. Aby to obliczyć, badamy każdy nieplanowany zakup na otwartym rynku dokonany przez insidera, z wyłączeniem wszystkich transakcji oznaczonych jako część planu handlowego 10b5-1. Następnie obliczamy średnią wydajność tych transakcji w ciągu 3, 6 i 12 miesięcy, uśredniając każdy z tych okresów, aby wygenerować ostateczny wskaźnik wydajności dla każdej transakcji. Na koniec uśredniamy wszystkie wskaźniki wydajności, aby obliczyć wskaźnik wydajności dla insidera. Na tej liście znajdują się wyłącznie insiderzy, którzy dokonali co najmniej trzech transakcji w ciągu ostatnich dwóch lat.
Jeśli rentowność handlu insiderów jest oznaczona notką„nie dotyczy”, oznacza to, że insider albo nie dokonał żadnych zakupów na otwartym rynku w ciągu ostatnich trzech lat, albo transakcje, których dokonał, są zbyt nowe, aby obliczyć wiarygodny wskaźnik wydajności.
Częstotliwość aktualizacji: codziennie
Spółki posiadające zgłoszone stanowiska osób mających dostęp do poufnych informacji
Z dokumentów SEC wynika, że John D Quisel zgłosił udziały lub transakcje w następujących spółkach:
| Papier wartościowy | Nazwa | Najnowsze raporty dotyczące udziałów |
|---|---|---|
| US:IRON / Disc Medicine, Inc. | Chief Executive Officer, Director | 226 064 |
| US:XLRN / Acceleron Pharma Inc | EVP, Chief Business Officer | 53 316 |
Jak interpretować wykresy
Poniższe wykresy przedstawiają notowania akcji papierów wartościowych po każdej niezaplanowanej transakcji na otwartym rynku dokonanej przez John D Quisel. Nieplanowane transakcje to transakcje, które nie zostały dokonane w ramach planu handlowego 10b5-1. Notowania akcji przedstawiono na wykresie jako skumulowaną procentową zmianę ceny akcji. Na przykład, jeśli 1 stycznia 2019 r. dokonano transakcji poufnej, wykres pokaże dzienną procentową zmianę papieru wartościowego do dnia dzisiejszego. Jeżeli cena akcji wzrosłaby w tym czasie z 10 do 15 dolarów, skumulowana procentowa zmiana ceny akcji wyniosłaby 50%. Zmiana ceny z 10$ na 20$ będzie wynosić 100%, a zmiana ceny z 10$ na 5$ będzie wynosić -50%.
Ostatecznie staramy się określić, jak blisko transakcje insiderów korelują z nadmiernymi zwrotami (dodatnimi lub ujemnymi) z ceny akcji, aby sprawdzić, czy insider dostosowuje swoje transakcje w taki sposób, aby czerpać korzyści z informacji poufnych. Rozważmy sytuację, w której zrobił to ktoś z wewnątrz. W tej sytuacji oczekiwalibyśmy albo (a) dodatnich zwrotów po zakupach, albo (b) ujemnych zwrotów po sprzedaży. W przypadku (a) wykres ZAKUPU pokazywałby serię krzywych nachylonych w górę, wskazujących dodatnie zwroty po każdej transakcji zakupu. W przypadku (b) wykres SPRZEDAŻ pokazywałby serię krzywych o nachyleniu w dół, wskazujących ujemne zwroty po każdej transakcji sprzedaży.
Samo to jednak nie wystarczy, aby wyciągnąć wnioski. Gdyby np. cena akcji spółki przez wiele lat rosła niecyklicznie, to spodziewalibyśmy się, że wszystkie wykresy po zakupie będą wykazywały tendencję wzrostową. Podobnie niecykliczne spadki na przestrzeni wielu lat spowodowałyby spadek linii na wykresie po transakcjach. Żaden z tych wykresów nie sugeruje wykorzystywania informacji poufnych.
Najsilniejszym wskaźnikiem byłaby sytuacja, gdy cena akcji miała charakter wyjątkowo cykliczny, a na wykresie KUPNO występowały zarówno pozytywne sygnały na wykresie KUPNA, jak i negatywne na wykresie SPRZEDAŻY. Sytuacja ta wysoce sugerowałaby osobę mającą dostęp do informacji poufnych, która wykorzystywała transakcje w celu uzyskania korzyści finansowej.
Historia handlu insiderów
Ta tabela przedstawia pełną listę transakcji insiderów dokonanych przez firmę John D Quisel ujawnioną Komisji Papierów Wartościowych (SEC).
| Data pliku | Data trans | Formularz | Ticker | Bezpieczeństwo | Kod | Akcje | Pozostałe akcje | Zmiana procent |
Cena udziału |
Wartość trans |
Pozostała Wartość |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-17 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
S - Sale | -13 264 | 226 064 | -5,54 | 62,86 | -833 775 | 14 210 383 | |
| 2026-02-11 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
A - Award | 55 200 | 239 328 | 29,98 | ||||
| 2025-12-19 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
M - Exercise | 12 300 | 184 128 | 7,16 | 1,01 | 12 423 | 185 969 | |
| 2025-12-15 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
S - Sale | X | -16 888 | 171 828 | -8,95 | 93,65 | -1 581 549 | 16 091 572 |
| 2025-12-15 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
S - Sale | X | -16 356 | 188 716 | -7,98 | 92,96 | -1 520 398 | 17 542 398 |
| 2025-12-15 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
S - Sale | X | -4 337 | 205 072 | -2,07 | 92,21 | -399 920 | 18 909 935 |
| 2025-12-15 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
S - Sale | X | -2 419 | 209 409 | -1,14 | 90,97 | -220 064 | 19 050 565 |
| 2025-12-15 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
M - Exercise | X | 40 000 | 211 828 | 23,28 | 9,86 | 394 400 | 2 088 624 |
| 2025-09-11 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
M - Exercise | 10 000 | 171 828 | 6,18 | 1,01 | 10 100 | 173 546 | |
| 2025-07-11 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
S - Sale | X | -3 593 | 161 828 | -2,17 | 56,20 | -201 925 | 9 094 653 |
| 2025-07-11 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
S - Sale | X | -31 207 | 165 421 | -15,87 | 55,23 | -1 723 600 | 9 136 400 |
| 2025-07-11 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
M - Exercise | X | 34 800 | 196 628 | 21,50 | 9,86 | 343 128 | 1 938 752 |
| 2025-07-08 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
S - Sale | X | -5 200 | 161 828 | -3,11 | 55,09 | -286 454 | 8 914 684 |
| 2025-07-08 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
M - Exercise | X | 5 200 | 167 028 | 3,21 | 9,86 | 51 272 | 1 646 896 |
| 2025-04-08 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
M - Exercise | 7 000 | 161 828 | 4,52 | 1,01 | 7 070 | 163 446 | |
| 2025-02-20 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
S - Sale | -5 574 | 154 828 | -3,48 | 54,58 | -304 229 | 8 450 512 | |
| 2025-02-12 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
A - Award | 78 337 | 160 402 | 95,46 | ||||
| 2025-01-02 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
M - Exercise | 10 000 | 82 065 | 13,88 | 1,01 | 10 100 | 82 886 | |
| 2025-01-02 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
S - Sale | X | -1 900 | 72 065 | -2,57 | 62,41 | -118 580 | 4 497 627 |
| 2025-01-02 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
S - Sale | X | -11 112 | 73 965 | -13,06 | 61,87 | -687 477 | 4 576 067 |
| 2025-01-02 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
M - Exercise | X | 13 012 | 85 077 | 18,06 | 9,86 | 128 298 | 838 859 |
| 2024-12-26 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
S - Sale | X | -4 212 | 72 065 | -5,52 | 63,80 | -268 733 | 4 597 870 |
| 2024-12-26 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
S - Sale | X | -12 194 | 76 277 | -13,78 | 63,12 | -769 667 | 4 814 490 |
| 2024-12-26 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
S - Sale | X | -3 414 | 88 471 | -3,72 | 62,38 | -212 957 | 5 518 617 |
| 2024-12-26 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
M - Exercise | X | 19 820 | 91 885 | 27,50 | 2,65 | 52 523 | 243 495 |
| 2024-12-18 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
S - Sale | X | -500 | 72 065 | -0,69 | 67,20 | -33 599 | 4 842 624 |
| 2024-12-18 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
S - Sale | X | -6 305 | 72 565 | -7,99 | 66,35 | -418 361 | 4 814 971 |
| 2024-12-18 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
S - Sale | X | -5 767 | 78 870 | -6,81 | 65,58 | -378 194 | 5 172 208 |
| 2024-12-18 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
S - Sale | X | -219 | 84 637 | -0,26 | 64,66 | -14 160 | 5 472 510 |
| 2024-12-18 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
M - Exercise | X | 12 791 | 84 856 | 17,75 | 1,01 | 12 919 | 85 705 |
| 2024-07-10 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
M - Exercise | 3 000 | 72 065 | 4,34 | 1,01 | 3 030 | 72 786 | |
| 2024-03-01 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
A - Award | 66 365 | 69 065 | 2 457,96 | ||||
| 2024-01-03 |
|
4 | IRON |
Disc Medicine, Inc.
Common Stock |
M - Exercise | 2 700 | 2 700 | 1,01 | 2 727 | 2 727 | ||
| 2020-01-03 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -4 242 | 53 316 | -7,37 | 52,52 | -222 790 | 2 800 156 |
| 2020-01-03 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 600 | 57 558 | -2,70 | 52,51 | -84 016 | 3 022 371 |
| 2019-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -3 584 | 59 158 | -5,71 | 45,23 | -162 104 | 2 675 716 |
| 2019-07-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | -1 562 | 0 | -100,00 | ||||
| 2019-07-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | -2 346 | 0 | -100,00 | ||||
| 2019-07-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | -5 000 | 0 | -100,00 | ||||
| 2019-07-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 1 562 | 62 742 | 2,55 | 7,12 | 11 121 | 446 723 | |
| 2019-07-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 2 346 | 61 180 | 3,99 | 5,28 | 12 387 | 323 030 | |
| 2019-07-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 5 000 | 58 834 | 9,29 | 3,88 | 19 400 | 228 276 | |
| 2019-04-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -70 | 53 834 | -0,13 | 44,24 | -3 097 | 2 381 616 |
| 2019-04-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -100 | 53 904 | -0,19 | 45,46 | -4 546 | 2 450 476 |
| 2019-04-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -3 452 | 54 004 | -6,01 | 44,62 | -154 028 | 2 409 658 |
| 2019-01-29 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 28 500 | 28 500 | |||||
| 2019-01-29 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 4 800 | 57 456 | 9,12 | ||||
| 2019-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -475 | 52 656 | -0,89 | 43,92 | -20 862 | 2 312 652 |
| 2019-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -2 558 | 53 131 | -4,59 | 43,10 | -110 250 | 2 289 946 |
| 2019-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 300 | 55 689 | -2,28 | 42,31 | -55 003 | 2 356 202 |
| 2019-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -300 | 56 989 | -0,52 | 43,26 | -12 978 | 2 465 344 |
| 2019-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 309 | 57 289 | -2,23 | 42,32 | -55 397 | 2 424 470 |
| 2018-05-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 10 000 | 10 000 | |||||
| 2018-05-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 2 000 | 58 598 | 3,53 | ||||
| 2018-04-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -100 | 56 598 | -0,18 | 39,16 | -3 916 | 2 216 378 |
| 2018-04-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 104 | 56 698 | -1,91 | 38,33 | -42 316 | 2 173 234 |
| 2018-03-05 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 28 950 | 28 950 | |||||
| 2018-03-05 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 4 825 | 57 802 | 9,11 | ||||
| 2018-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -4 333 | 52 977 | -7,56 | 42,42 | -183 806 | 2 247 284 |
| 2017-09-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -8 | 57 310 | -0,01 | 38,03 | -304 | 2 179 499 |
| 2017-09-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -600 | 57 318 | -1,04 | 39,37 | -23 622 | 2 256 610 |
| 2017-09-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -4 505 | 57 918 | -7,22 | 38,29 | -172 496 | 2 217 680 |
| 2017-03-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 46 300 | 46 300 | |||||
| 2017-03-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 7 900 | 62 423 | 14,49 | ||||
| 2017-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 400 | 54 523 | -2,50 | 27,56 | -38 584 | 1 502 654 |
| 2017-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -300 | 55 923 | -0,53 | 26,43 | -7 929 | 1 478 045 |
| 2016-09-23 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -11 500 | 5 000 | -69,70 | |||
| 2016-09-23 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -13 671 | 15 329 | -47,14 | |||
| 2016-09-23 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -781 | 1 562 | -33,33 | |||
| 2016-09-23 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -45 952 | 56 223 | -44,97 | 38,05 | -1 748 474 | 2 139 285 |
| 2016-09-23 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 11 500 | 102 175 | 12,68 | 3,88 | 44 620 | 396 439 |
| 2016-09-23 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 13 671 | 90 675 | 17,75 | 24,11 | 329 608 | 2 186 174 |
| 2016-09-23 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 781 | 77 004 | 1,02 | 7,12 | 5 561 | 548 268 |
| 2016-09-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -4 688 | 2 343 | -66,68 | |||
| 2016-09-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -6 250 | 0 | -100,00 | |||
| 2016-09-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -5 500 | 16 500 | -25,00 | |||
| 2016-09-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -21 438 | 76 223 | -21,95 | 32,14 | -689 017 | 2 449 807 |
| 2016-09-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 688 | 97 661 | 5,04 | 7,12 | 33 379 | 695 346 |
| 2016-09-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 6 250 | 92 973 | 7,21 | 5,28 | 33 000 | 490 897 |
| 2016-09-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 500 | 86 723 | 6,77 | 3,88 | 21 340 | 336 485 |
| 2016-03-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 30 800 | 30 800 | |||||
| 2016-03-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 5 100 | 81 223 | 6,70 | ||||
| 2015-09-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -5 500 | 22 000 | -20,00 | |||
| 2015-09-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 400 | 76 123 | -1,81 | 34,17 | -47 838 | 2 601 123 |
| 2015-09-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -4 100 | 77 523 | -5,02 | 33,07 | -135 587 | 2 563 686 |
| 2015-09-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 500 | 81 623 | 7,23 | 3,88 | 21 340 | 316 697 |
| 2015-09-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 40 000 | 76 123 | 110,73 | ||||
| 2015-08-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -1 039 | 27 500 | -3,64 | |||
| 2015-08-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -4 461 | 0 | -100,00 | |||
| 2015-08-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -2 200 | 36 123 | -5,74 | 31,74 | -69 828 | 1 146 544 |
| 2015-08-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -3 300 | 38 323 | -7,93 | 30,22 | -99 726 | 1 158 121 |
| 2015-08-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 039 | 41 623 | 2,56 | 3,88 | 4 031 | 161 497 |
| 2015-08-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 461 | 40 584 | 12,35 | 5,88 | 26 231 | 238 634 |
| 2015-08-03 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | -5 895 | 6 250 | -48,54 | ||||
| 2015-08-03 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | -7 527 | 2 346 | -76,24 | ||||
| 2015-08-03 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 5 895 | 36 123 | 19,50 | 5,28 | 31 126 | 190 729 | |
| 2015-08-03 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 7 527 | 30 228 | 33,16 | 5,28 | 39 743 | 159 604 | |
| 2015-07-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -5 500 | 4 461 | -55,22 | |||
| 2015-07-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -5 500 | 22 701 | -19,50 | 30,00 | -165 000 | 681 030 |
| 2015-07-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 500 | 28 201 | 24,23 | 5,88 | 32 340 | 165 822 |
| 2015-06-18 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | -7 701 | 28 539 | -21,25 | ||||
| 2015-06-18 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 7 701 | 22 701 | 51,34 | 3,88 | 29 880 | 88 080 | |
| 2015-06-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -5 500 | 9 961 | -35,57 | |||
| 2015-06-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -5 500 | 15 000 | -26,83 | 31,13 | -171 215 | 466 950 |
| 2015-06-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 500 | 20 500 | 36,67 | 5,88 | 32 340 | 120 540 |
| 2015-05-18 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -5 500 | 15 461 | -26,24 | |||
| 2015-05-18 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -3 900 | 15 000 | -20,63 | 31,81 | -124 059 | 477 150 |
| 2015-05-18 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 600 | 18 900 | -7,80 | 31,06 | -49 696 | 587 034 |
| 2015-05-18 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 500 | 20 500 | 36,67 | 5,88 | 32 340 | 120 540 |
| 2015-03-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -4 039 | 20 961 | -16,16 | |||
| 2015-03-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -1 461 | 0 | -100,00 | |||
| 2015-03-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -220 | 15 000 | -1,45 | 41,20 | -9 064 | 618 000 |
| 2015-03-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -5 280 | 15 220 | -25,76 | 40,67 | -214 738 | 618 997 |
| 2015-03-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 039 | 20 500 | 24,54 | 5,88 | 23 749 | 120 540 |
| 2015-03-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 461 | 16 461 | 9,74 | 5,88 | 8 591 | 96 791 |
| 2015-03-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -4 000 | 0 | -100,00 | |||
| 2015-03-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -800 | 15 000 | -5,06 | 42,05 | -33 640 | 630 750 |
| 2015-03-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -3 200 | 15 800 | -16,84 | 41,28 | -132 096 | 652 224 |
| 2015-03-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 000 | 19 000 | 26,67 | 5,08 | 20 320 | 96 520 |
| 2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -5 500 | 1 461 | -79,01 | |||
| 2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -2 000 | 4 000 | -33,33 | |||
| 2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -2 000 | 4 000 | -33,33 | |||
| 2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -101 | 15 000 | -0,67 | 42,06 | -4 248 | 630 900 |
| 2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 066 | 15 101 | -6,59 | 41,77 | -44 527 | 630 769 |
| 2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -4 333 | 16 167 | -21,14 | 40,34 | -174 793 | 652 177 |
| 2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 500 | 20 500 | 36,67 | 5,88 | 32 340 | 120 540 |
| 2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 | 15 000 | -0,01 | 42,07 | -42 | 631 050 |
| 2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 300 | 15 001 | -7,97 | 41,50 | -53 950 | 622 542 |
| 2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -2 699 | 16 301 | -14,21 | 40,65 | -109 714 | 662 636 |
| 2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 000 | 19 000 | 11,76 | 5,08 | 10 160 | 96 520 |
| 2015-03-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 000 | 17 000 | 13,33 | 1,80 | 3 600 | 30 600 |
| 2015-01-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -2 438 | 6 961 | -25,94 | |||
| 2015-01-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -1 500 | 6 000 | -20,00 | |||
| 2015-01-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -1 562 | 12 145 | -11,40 | |||
| 2015-01-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -500 | 2 000 | -20,00 | |||
| 2015-01-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -3 500 | 0 | -100,00 | |||
| 2015-01-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -5 500 | 15 000 | -26,83 | 40,12 | -220 660 | 601 800 |
| 2015-01-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 438 | 20 500 | 13,50 | 5,88 | 14 335 | 120 540 |
| 2015-01-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 500 | 18 062 | 9,06 | 5,08 | 7 620 | 91 755 |
| 2015-01-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 562 | 16 562 | 10,41 | 5,28 | 8 247 | 87 447 |
| 2015-01-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -500 | 15 000 | -3,23 | 40,62 | -20 310 | 609 300 |
| 2015-01-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -3 500 | 15 500 | -18,42 | 39,85 | -139 475 | 617 675 |
| 2015-01-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 500 | 19 000 | 2,70 | 1,80 | 900 | 34 200 |
| 2015-01-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 500 | 18 500 | 23,33 | 0,92 | 3 220 | 17 020 |
| 2015-01-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 41 000 | 41 000 | |||||
| 2014-12-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | -15 000 | 36 240 | -29,27 | ||||
| 2014-12-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 15 000 | 15 000 | 3,88 | 58 200 | 58 200 | ||
| 2014-12-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -4 000 | 3 500 | -53,33 | |||
| 2014-12-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -2 500 | 0 | -100,00 | 41,72 | -104 300 | |
| 2014-12-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 500 | 2 500 | -37,50 | 40,72 | -61 080 | 101 800 |
| 2014-12-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 000 | 4 000 | 0,92 | 3 680 | 3 680 | |
| 2014-11-18 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -4 000 | 7 500 | -34,78 | |||
| 2014-11-18 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -675 | 0 | -100,00 | 34,72 | -23 436 | |
| 2014-11-18 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -3 325 | 675 | -83,12 | 33,24 | -110 523 | 22 437 |
| 2014-11-18 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 000 | 4 000 | 0,92 | 3 680 | 3 680 | |
| 2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -1 899 | 7 031 | -21,27 | |||
| 2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -3 101 | 9 399 | -24,81 | |||
| 2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -3 043 | 0 | -100,00 | 33,60 | -102 245 | |
| 2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 957 | 3 043 | -39,14 | 32,42 | -63 446 | 98 654 |
| 2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 899 | 5 000 | 61,24 | 7,12 | 13 521 | 35 600 |
| 2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 101 | 3 101 | 5,88 | 18 234 | 18 234 | |
| 2014-10-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -4 000 | 11 500 | -25,81 | |||
| 2014-10-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -4 000 | 0 | -100,00 | 29,02 | -116 080 | |
| 2014-10-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 000 | 4 000 | 0,92 | 3 680 | 3 680 | |
| 2014-10-01 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -3 570 | 8 930 | -28,56 | |||
| 2014-10-01 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -3 430 | 13 707 | -20,02 | |||
| 2014-10-01 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -7 000 | 0 | -100,00 | 30,01 | -210 070 | |
| 2014-10-01 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 570 | 7 000 | 104,08 | 7,12 | 25 418 | 49 840 |
| 2014-10-01 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 430 | 3 430 | 5,28 | 18 110 | 18 110 | |
| 2014-09-12 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -2 000 | 15 500 | -11,43 | |||
| 2014-09-12 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -2 000 | 0 | -100,00 | 25,43 | -50 860 | |
| 2014-09-12 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 000 | 2 000 | 0,92 | 1 840 | 1 840 | |
| 2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -7 863 | 17 137 | -31,45 | |||
| 2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -3 137 | 9 873 | -24,11 | |||
| 2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -2 000 | 17 500 | -10,26 | |||
| 2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -11 000 | 0 | -100,00 | 30,02 | -330 220 | |
| 2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 7 863 | 11 000 | 250,65 | 5,28 | 41 517 | 58 080 |
| 2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 137 | 3 137 | 5,28 | 16 563 | 16 563 | |
| 2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -2 000 | 0 | -100,00 | 29,79 | -59 580 | |
| 2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 000 | 2 000 | 0,92 | 1 840 | 1 840 | |
| 2014-07-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -3 000 | 13 010 | -18,74 | |||
| 2014-07-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -2 000 | 19 500 | -9,30 | |||
| 2014-07-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -3 000 | 0 | -100,00 | 30,12 | -90 360 | |
| 2014-07-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 000 | 3 000 | 5,28 | 15 840 | 15 840 | |
| 2014-07-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -900 | 0 | -100,00 | 29,71 | -26 739 | |
| 2014-07-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 100 | 900 | -55,00 | 28,70 | -31 570 | 25 830 |
| 2014-07-16 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 000 | 2 000 | 0,92 | 1 840 | 1 840 | |
| 2014-07-02 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to purchase Common Stock |
A - Award | 10 000 | 10 000 | |||||
| 2014-06-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to purchase Common Stock |
M - Exercise | X | -2 740 | 16 010 | -14,61 | |||
| 2014-06-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to purchase Common Stock |
M - Exercise | X | -4 260 | 51 240 | -7,68 | |||
| 2014-06-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to purchase Common Stock |
M - Exercise | X | -2 000 | 21 500 | -8,51 | |||
| 2014-06-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -2 700 | 0 | -100,00 | 34,13 | -92 151 | |
| 2014-06-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -6 300 | 2 700 | -70,00 | 33,86 | -213 318 | 91 422 |
| 2014-06-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 740 | 9 000 | 43,77 | 5,28 | 14 467 | 47 520 |
| 2014-06-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 260 | 6 260 | 213,00 | 3,88 | 16 529 | 24 289 |
| 2014-06-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 000 | 2 000 | 0,92 | 1 840 | 1 840 | |
| 2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -7 000 | 55 500 | -11,20 | |||
| 2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -2 000 | 23 500 | -7,84 | |||
| 2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -900 | 0 | -100,00 | 32,20 | -28 980 | |
| 2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -6 100 | 900 | -87,14 | 31,29 | -190 869 | 28 161 |
| 2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 7 000 | 7 000 | 3,88 | 27 160 | 27 160 | |
| 2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -2 000 | 0 | -100,00 | 31,49 | -62 980 | |
| 2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 000 | 2 000 | 0,92 | 1 840 | 1 840 | |
| 2014-04-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -2 000 | 25 500 | -7,27 | |||
| 2014-04-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -500 | 0 | -100,00 | 36,13 | -18 065 | |
| 2014-04-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 500 | 500 | -75,00 | 35,75 | -53 625 | 17 875 |
| 2014-04-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 000 | 2 000 | 0,92 | 1 840 | 1 840 | |
| 2013-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 29 000 | 29 000 |